CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Advantages of Using Monoclonal Antibodies

Advantages of Using Monoclonal...

A Brief Overview Of Green Biotechnology Tools And Applications

A Brief Overview Of Green...

Key Advantages of Agtech in Farming

Key Advantages of Agtech in Farming

Nanotechnologys Impact on Environment: What to Know

Nanotechnologys Impact on...

How Automation in Pharmaceutical is Giving a New Direction to Drug Development

How Automation in Pharmaceutical is...

Ways Health Economics and Outcomes Research can Improve Decision Making Process

Ways Health Economics and Outcomes...

Top Agtech Industry Trends to Keep an Eye on

Top Agtech Industry Trends to Keep an...

Strategies to Mitigate Life Sciences Supply Chain Challenges

Strategies to Mitigate Life Sciences...

Advantages of Using Monoclonal Antibodies

Advantages of Using Monoclonal...

A Brief Overview Of Green Biotechnology Tools And Applications

A Brief Overview Of Green...

Key Advantages of Agtech in Farming

Key Advantages of Agtech in Farming

Nanotechnologys Impact on Environment: What to Know

Nanotechnologys Impact on...

How Automation in Pharmaceutical is Giving a New Direction to Drug Development

How Automation in Pharmaceutical is...

Ways Health Economics and Outcomes Research can Improve Decision Making Process

Ways Health Economics and Outcomes...

Top Agtech Industry Trends to Keep an Eye on

Top Agtech Industry Trends to Keep an...

Strategies to Mitigate Life Sciences Supply Chain Challenges

Strategies to Mitigate Life Sciences...

The Emerging Relevance of Genomics in Cancer Treatment and Care

Life Sciences Review | Thursday, October 29, 2020
Tweet

Beyond identifying targetable alterations, genomic methods can identify cancer-specific proteins that inform the design of personalized treatment and care.


FREMONT, CA: When the cancer was first described, there were just two forms. But in the late nineteenth century, physicians found that cancer had several cellular forms with the help of the microscope. Now, innovative technology is once again transforming the understanding of cancer's origins and complexity. Instead of extensive categorizations based on the location of tumors, genome sequencing offers detailed characterizations of the combination of genetic mutations that trigger cancer development in an individual. Several oncology researchers and practitioners study genetic alterations in cancer, but they either focus on tumor type or mutation that happens across tumors. A study focusing on precision medicine in cancer is now offering evidence that even more, comprehensive gene testing should be routine in cancer research, treatment, and care.


As well as advancing understanding of what causes cancer, genomics is offering insights into how an individual's cancer might progress and its likely response to treatment. For some, this data will save their lives; knowledge of cancer's genetic drivers is already changing how some people's cancer is treated. For others, it only adds new data, not years to their lives or new treatment choices. 


But each cancer-causing or cancer-influencing genetic mutation found is a potential target for drug development, including for cancers for which there are presently few treatment choices.


Identifying cancer-causing mutations can be vital to diagnosis, especially when it comes to hematological cancers. One of the major impacts that cancer genomics has treatment choices. Having the right diagnosis is the most vital determinant of getting the right treatment. The possibility of treating cancer-based on an individual tumor's genetic profile can cause a surge in patients' cancer-genome profiling.


Targeted therapies have become vital in cancer treatment and research. Efforts are also being made to tackle resistance to targeted treatments. The researchers believe their findings confirm the value of tumor gene testing to find the best treatment plan for patients and offer a roadmap for future precision medicine trials.


Weekly Brief

loading
Towards a New World Order
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

The Importance of Technology in Multinational Clinical Research

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/the-emerging-relevance-of-genomics-in-cancer-treatment-and-care-nwid-154.html